Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Bio-Rad Laboratories (BIO) Non-Current Deffered Revenue (2016)

Historic Non-Current Deffered Revenue for Bio-Rad Laboratories (BIO) over the last 2 years, with Q3 2016 value amounting to $4.4 million.

Bio-Rad Laboratories' Non-Current Deffered Revenue changed N/A to $4.4 million in Q3 2016 from the same period last year, while for Sep 2016 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2015, which is N/A changed from last year.
As of Q3 2016, Bio-Rad Laboratories' Non-Current Deffered Revenue stood at $4.4 million.
Over the past 5 years, Bio-Rad Laboratories' Non-Current Deffered Revenue peaked at $4.4 million during Q3 2016, and registered a low of $3.7 million during Q4 2015.